Sound Capital Solutions’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
Other funds holding MLTX
Sound Capital Solutions's MLTX Position: Q3 2026 in Review
Sound Capital Solutions sold out of MoonLake Immunotherapeutics (MLTX) in Q3 2026, closing a stake of 24,335 shares — an estimated $474K sold.
Sound Capital Solutions first reported a position in MLTX in Q2 2026 and held it in 1 quarter. The position peaked at $474K in Q2 2026. 170 funds tracked by Wall St. Rank hold MLTX as of Q3 2026.
- Sound Capital Solutions reported no remaining MoonLake Immunotherapeutics position as of Q3 2026 after selling out during the quarter.
- Sound Capital Solutions sold 24,335 MoonLake Immunotherapeutics shares in Q3 2026, an estimated $474K.
- Sound Capital Solutions first reported a position in MoonLake Immunotherapeutics in Q2 2026 and held it in 1 quarter.
- Sound Capital Solutions's MoonLake Immunotherapeutics position peaked at $474K in Q2 2026.
- 170 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q3 2026.
Based on Sound Capital Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.